Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Labetalol-induced hyperkalemia in renal transplant recipients
Jerry McCauley
, Joan Murray
, Mark Jordan
, Velma Scantlebury
, Carlos Vivas
, Ron Shapiro
Research output
:
Contribution to journal
›
Article
›
peer-review
34
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Labetalol-induced hyperkalemia in renal transplant recipients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Hyperkalemia
100%
Renal Transplant Recipients
100%
Labetalol
100%
Cold Ischemia
20%
Renal Transplantation
20%
Urine Output
20%
24-hour Urine Collection
20%
Retrospective Review
10%
Diabetes
10%
Confidence Interval
10%
Odds Ratio
10%
Beta-blockers
10%
Mannitol
10%
Logistic Regression Model
10%
Tacrolimus
10%
Life-threatening
10%
Renal Transplant
10%
Angiotensin-converting Enzyme Inhibitor (ACEi)
10%
Time Method
10%
Continuous Ambulatory Peritoneal Dialysis
10%
Perioperative Hypertension
10%
Hyperkalemia Treatment
10%
Dialysis Method
10%
Labetolol
10%
Pharmacology, Toxicology and Pharmaceutical Science
Hyperkalemia
100%
Labetalol
100%
Ischemia
18%
Beta Adrenergic Receptor Blocking Agent
9%
Tacrolimus
9%
Dipeptidyl Carboxypeptidase Inhibitor
9%
Mannitol
9%
Antihypertensive
9%
Hypertension
9%